|
MA41179A
(fr)
|
2014-12-19 |
2017-10-24 |
Cancer Research Tech Ltd |
Composés inhibiteurs de parg
|
|
US20250002491A1
(en)
|
2021-10-04 |
2025-01-02 |
Forx Therapeutics Ag |
N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancer
|
|
AU2022359801A1
(en)
|
2021-10-04 |
2024-02-01 |
Forx Therapeutics Ag |
Parg inhibitory compounds
|
|
AR128499A1
(es)
*
|
2022-02-14 |
2024-05-15 |
Arase Therapeutics Inc |
Inhibidores de parg
|
|
WO2023165571A1
(zh)
|
2022-03-04 |
2023-09-07 |
上海璎黎药业有限公司 |
一种含五元杂芳环结构化合物、其药物组合物及应用
|
|
WO2023175184A1
(en)
|
2022-03-17 |
2023-09-21 |
Forx Therapeutics Ag |
2,4-dioxo-1,4-dihydroquinazoline derivatives as parg inhibitors for the treatment of cancer
|
|
WO2023175185A1
(en)
|
2022-03-17 |
2023-09-21 |
Forx Therapeutics Ag |
2,4-dioxo-1,4-dihydroquinazoline derivatives as parg inhibitors for the treatment of cancer
|
|
AR128846A1
(es)
|
2022-03-23 |
2024-06-19 |
Ideaya Biosciences Inc |
Compuestos de indazol sustituidos con piperazina como inhibidores de parg
|
|
CN118834213A
(zh)
*
|
2022-04-28 |
2024-10-25 |
北京丹擎医药科技有限公司 |
三环杂环衍生物及其组合物和应用
|
|
WO2023224998A1
(en)
*
|
2022-05-17 |
2023-11-23 |
858 Therapeutics, Inc. |
Inhibitors of parg
|
|
CA3251429A1
(en)
|
2022-05-17 |
2023-11-23 |
858 Therapeutics, Inc. |
PARG INHIBITORS
|
|
TWI878939B
(zh)
*
|
2022-06-29 |
2025-04-01 |
大陸商杭州聖域生物醫藥科技有限公司 |
五元並六元含氮化物、其中間體、製備方法和應用
|
|
AU2023310489A1
(en)
*
|
2022-07-19 |
2025-02-13 |
Evopoint Biosciences Co., Ltd. |
Sulfur-containing heteroaromatic ring compound, pharmaceutical composition thereof, and use thereof
|
|
EP4311829A1
(en)
|
2022-07-28 |
2024-01-31 |
Nodus Oncology Limited |
Substituted bicyclic heteroaryl sulfonamide derivatives for the treatment of cancer
|
|
JP2025535036A
(ja)
|
2022-10-03 |
2025-10-22 |
フォークス セラピューティクス アーゲー |
Ｐａｒｇ阻害化合物
|
|
KR20240051861A
(ko)
*
|
2022-10-13 |
2024-04-22 |
한미약품 주식회사 |
Yap-tead 상호작용 억제를 위한 신규한 헤테로비시클릭 화합물 및 이를 포함하는 약학적 조성물
|
|
EP4646208A1
(en)
|
2023-01-06 |
2025-11-12 |
Ideaya Biosciences, Inc. |
Treatment of er+ breast cancer comprising homologous recombination deficiency using parg inhibitor
|
|
WO2024173234A1
(en)
*
|
2023-02-13 |
2024-08-22 |
Arase Therapeutics Inc. |
Inhibitors of parg
|
|
WO2024173514A1
(en)
*
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Amide and ester-substituted imidazopyridine compounds
|
|
WO2024173524A1
(en)
*
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Heteroaryl-substituted benzimidazole compounds
|
|
WO2024173453A1
(en)
*
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Heteroaryl-substituted imidazopyridine compounds
|
|
WO2024173530A1
(en)
*
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Heteroaryl-substituted pyrazolo/imidazo pyridine compounds
|
|
WO2024209035A1
(en)
|
2023-04-05 |
2024-10-10 |
Forx Therapeutics Ag |
Parg inhibitory compounds
|
|
WO2024211506A1
(en)
|
2023-04-05 |
2024-10-10 |
Ideaya Biosciences, Inc. |
Combination therapy comprising a parg inhibitor and a topoisomerase inhibitor for treating cancer
|
|
TWI908044B
(zh)
*
|
2023-04-27 |
2025-12-11 |
大陸商北京丹擎醫藥科技有限公司 |
三環雜環衍生物及其組合物及其用途
|
|
CN119143747A
(zh)
*
|
2023-06-16 |
2024-12-17 |
上海璎黎药业有限公司 |
一种杂芳环结构化合物、其药物组合物及应用
|
|
WO2025046148A1
(en)
|
2023-09-01 |
2025-03-06 |
Forx Therapeutics Ag |
Novel parg inhibitors
|
|
TW202528308A
(zh)
*
|
2023-09-20 |
2025-07-16 |
美商愛德亞生物科學公司 |
Parg抑制劑
|
|
AU2024344078A1
(en)
|
2023-09-20 |
2026-04-02 |
Ideaya Biosciences, Inc. |
Combination therapy with a parg inhibitor
|
|
WO2025072544A1
(en)
*
|
2023-09-27 |
2025-04-03 |
Ideaya Biosciences, Inc. |
Sulfonamino indazole compounds as inhibitors of parg
|
|
CN119708015A
(zh)
*
|
2023-09-28 |
2025-03-28 |
杭州圣域生物医药科技有限公司 |
杂芳基化合物、其中间体、制备方法和应用
|
|
CN121889393A
(zh)
|
2023-10-03 |
2026-04-17 |
福克斯治疗股份公司 |
Parg抑制化合物
|
|
CN119859145A
(zh)
*
|
2023-10-20 |
2025-04-22 |
上海璎黎药业有限公司 |
一种杂芳环磺酰胺结构化合物、其药物组合物及应用
|
|
WO2025087941A1
(en)
|
2023-10-23 |
2025-05-01 |
Universite De Geneve |
Parg inhibitors in combination with parp inhibitors and uses thereof
|
|
TW202523299A
(zh)
*
|
2023-10-26 |
2025-06-16 |
大陸商上海齊魯製藥研究中心有限公司 |
Parg抑制劑
|
|
WO2025093755A1
(en)
|
2023-11-01 |
2025-05-08 |
Forx Therapeutics Ag |
Novel parc inhibitors
|
|
WO2025098445A1
(zh)
*
|
2023-11-07 |
2025-05-15 |
南京同诺康医药科技有限公司 |
Parg抑制剂及其制备方法和用途
|
|
WO2025108225A1
(zh)
*
|
2023-11-20 |
2025-05-30 |
上海复星医药（集团）股份有限公司 |
作为parg抑制剂的含氮三环衍生物
|
|
WO2025111339A1
(en)
*
|
2023-11-21 |
2025-05-30 |
858 Therapeutics, Inc. |
Treatment of cancer with a parg inhibitor
|
|
AR134429A1
(es)
*
|
2023-11-22 |
2026-01-14 |
858 Therapeutics Inc |
Inhibidores de parg
|
|
WO2025133191A1
(en)
*
|
2023-12-22 |
2025-06-26 |
Genecode |
Novel sulfonamides or sulfones and their use as neuroprotective and/or neurorestorative agents
|
|
WO2025133396A1
(en)
|
2023-12-22 |
2025-06-26 |
Forx Therapeutics Ag |
Novel bicyclo heteroaryl parg inhibitors
|
|
WO2025229549A1
(en)
*
|
2024-04-30 |
2025-11-06 |
Satyarx Pharma Innovations Pvt Ltd |
Novel heterocyclic compounds as inhibitors of parg
|
|
CN118459452B
(zh)
*
|
2024-07-10 |
2024-10-25 |
苏州国匡医药科技有限公司 |
一种多聚adp核糖水解酶抑制剂及其应用
|
|
WO2026022150A1
(en)
|
2024-07-22 |
2026-01-29 |
Forx Therapeutics Ag |
Parg inhibitory compounds
|
|
WO2026026739A1
(zh)
*
|
2024-07-29 |
2026-02-05 |
海思科医药集团股份有限公司 |
一种磺酰胺化合物及其在医药上的应用
|
|
WO2026032385A1
(zh)
*
|
2024-08-07 |
2026-02-12 |
上海亚虹医药科技有限公司 |
多聚adp核糖水解酶抑制剂及其医药用途
|
|
WO2026040953A1
(zh)
*
|
2024-08-19 |
2026-02-26 |
上海和誉生物医药科技有限公司 |
一种多环parg抑制剂和其应用
|
|
US20260055095A1
(en)
*
|
2024-08-23 |
2026-02-26 |
Recursion Pharmaceuticals, Inc. |
Novel compounds and uses thereof
|
|
WO2026062066A1
(en)
|
2024-09-17 |
2026-03-26 |
Forx Therapeutics Ag |
Compounds inducing parg degradation
|